Nanoparticle Delivery of Immunostimulatory Agents for Cancer Immunotherapy
Sign Up to like & getrecommendations! Published in 2019 at "Theranostics"
DOI: 10.7150/thno.37216
Abstract: Immunostimulatory agents, including adjuvants, cytokines, and monoclonal antibodies, hold great potential for the treatment of cancer. However, their direct administration often results in suboptimal pharmacokinetics, vulnerability to biodegradation, and compromised targeting. More recently, encapsulation into… read more here.
Keywords: delivery; nanoparticle delivery; immunostimulatory agents; cancer immunotherapy ... See more keywords